164 related articles for article (PubMed ID: 17998417)
1. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Meier DS; Weiner HL; Guttmann CR
AJNR Am J Neuroradiol; 2007; 28(10):1956-63. PubMed ID: 17998417
[TBL] [Abstract][Full Text] [Related]
2. MRI time series modeling of MS lesion development.
Meier DS; Guttmann CR
Neuroimage; 2006 Aug; 32(2):531-7. PubMed ID: 16806979
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
Janardhan V; Suri S; Bakshi R
Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
[TBL] [Abstract][Full Text] [Related]
4. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
[TBL] [Abstract][Full Text] [Related]
5. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging.
Miki Y; Grossman RI; Udupa JK; van Buchem MA; Wei L; Phillips MD; Patel U; McGowan JC; Kolson DL
Radiology; 1999 Mar; 210(3):769-74. PubMed ID: 10207480
[TBL] [Abstract][Full Text] [Related]
6. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability.
Filippi M; Rossi P; Campi A; Colombo B; Pereira C; Comi G
AJNR Am J Neuroradiol; 1997 Sep; 18(8):1549-56. PubMed ID: 9296198
[TBL] [Abstract][Full Text] [Related]
7. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
[TBL] [Abstract][Full Text] [Related]
8. Thalamic damage and long-term progression of disability in multiple sclerosis.
Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
[TBL] [Abstract][Full Text] [Related]
9. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.
Barnett M; Bergsland N; Weinstock-Guttman B; Butzkueven H; Kalincik T; Desmond P; Gaillard F; van Pesch V; Ozakbas S; Rojas JI; Boz C; Altintas A; Wang C; Dwyer MG; Yang S; Jakimovski D; Kyle K; Ramasamy DP; Zivadinov R
Neuroimage Clin; 2021; 32():102802. PubMed ID: 34469848
[TBL] [Abstract][Full Text] [Related]
11. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
12. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
13. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis--preliminary results.
Losseff NA; Miller DH; Kidd D; Thompson AJ
Mult Scler; 2001 Feb; 7(1):23-5. PubMed ID: 11321189
[TBL] [Abstract][Full Text] [Related]
15. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
Cotton F; Weiner HL; Jolesz FA; Guttmann CR
Neurology; 2003 Feb; 60(4):640-6. PubMed ID: 12601106
[TBL] [Abstract][Full Text] [Related]
16. The evolution of multiple sclerosis lesions on serial MR.
Guttmann CR; Ahn SS; Hsu L; Kikinis R; Jolesz FA
AJNR Am J Neuroradiol; 1995 Aug; 16(7):1481-91. PubMed ID: 7484637
[TBL] [Abstract][Full Text] [Related]
17. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
Paolillo A; Pozzilli C; Gasperini C; Giugni E; Mainero C; Giuliani S; Tomassini V; Millefiorini E; Bastianello S
J Neurol Sci; 2000 Mar; 174(2):85-91. PubMed ID: 10727693
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
19. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Tourdias T; Roggerone S; Filippi M; Kanagaki M; Rovaris M; Miller DH; Petry KG; Brochet B; Pruvo JP; Radüe EW; Dousset V
Radiology; 2012 Jul; 264(1):225-33. PubMed ID: 22723563
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
